BSEDeccan Health Care Limited· Healthcare ServicesHighNeutral
Announced Thu, 10 Sept, 2026 · 17:21 IST

Deccan Health Care Annual Report FY25-26: Revenue up 18.7%, PAT up 91%

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.3%Reaction day
₹12.22
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+2.2% vs market
Healthcare Service Provider peers, median of 26sector-0.7%+3.0% vs sector

On the reaction day the stock moved 2.2 pts more than Nifty Microcap 250 and 3.0 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.3+0.1+2.2-0.7+3.0
Next day
+3.8-3.2+7.0-0.6+4.5
2d
+2.0-3.3+5.3-2.1+4.2
3d
-0.5-2.5+2.0-0.6+0.1
4d
-5.4-0.9-4.5-0.5-4.9
5d
+1.4-1.1+2.4-0.7+2.1
1w
+2.4+0.6+1.7-1.1+3.5
15d
-3.4-1.4-2.0-4.7+1.4
1m
+4.6-3.3+7.9-5.8+10.3
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Deccan Health Care posted FY25-26 standalone revenue of Rs 8,917.97 lakhs (up 18.7%) and net profit of Rs 229.04 lakhs (up 91.2%). EPS rose 66.1% to Rs 0.93. Consolidated PAT jumped 114.7% to Rs 248.76 lakhs. EBITDA grew 46.7% with margins improving from 1.59% to 2.57%. The nutraceutical firm expanded digital platforms, launched multiple products, and entered UAE and African markets. 30th AGM set for 30 September 2026 via video conferencing.

Likely market impact

Strong double-digit revenue and triple-digit profit growth signal improved efficiency and global expansion momentum for shareholders.